Merck & Co., Inc. is 16.0x more valuable than Viatris Inc by market capitalization ($293.16 B vs $18.36 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VTRS | MRK |
|---|---|---|
| Market cap | $18.36 B | $293.16 B |
| US-listed rank | #647 | #44 |
| Revenue (latest FY) | $14.25B | $65.01B |
| Net income (latest FY) | $0.00 | $18.25B |
| Net margin | 0.0% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 519 | 996 |
Merck & Co., Inc. is 16.0x more valuable than Viatris Inc by market capitalization ($293.16 B vs $18.36 B).
In their latest fiscal years, Viatris Inc reported $14.25B in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Viatris Inc and Merck & Co., Inc., or browse the full rankings.